Effects of intravitreal bevacizumab on reduced visual acuity and macular thickness secondary to branch retinal vein occlusion
Kadir Eltutar, Fahreddin Acar, Nurhan Dincer, Sibel Zirtiloglu, Erkan Unsal Istanbul Training and Research Hospital, Istanbul, Turkey Background: The purpose of this study was to evaluate the effects of intravitreal bevacizumab injection in the treatment of macular thickness and reduced visual acuit...
Saved in:
Main Authors: | Eltutar K, Acar F, Dincer N, Zirtiloglu S, Unsal E |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/e4e3fc9a33de42bd8bbf69d9be4d4c90 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
by: Thapa R, et al.
Published: (2012) -
The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
by: Gokce G, et al.
Published: (2014) -
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
by: Juan Carlos Mesa Gutiérrez, et al.
Published: (2008) -
Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
by: Demir M, et al.
Published: (2011) -
VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF BRANCH RETINAL VEIN OCCLUSION
by: Saquib Naeem, et al.
Published: (2019)